<DOC>
	<DOCNO>NCT02328053</DOCNO>
	<brief_summary>The study randomise control trial ass visual clinical outcome collagen cross link fungal keratitis . Fungal keratitis major cause corneal blindness India therapeutic option available minimal handle advance complication sequalae cause disease.The antimicrobial tissue remodel role corneal cross link demonstrate several study earlier , ante specifically assess role corneal cross link non resolve fungal keratitis prevention perforation enhancement heal process .</brief_summary>
	<brief_title>Clinical &amp; Visual Outcomes Collagen Cross Linking Fungal Keratitis</brief_title>
	<detailed_description>Patients culture positive deep stromal fungal keratitis respond appropriate medical therapy period two week randomize receive receive adjuvant CXL . The medical therapy continue group follow 6 week randomization . Healing ulcer take successful outcome , perforation increase ulcer size 2 sq.mm baseline consider treatment failure .</detailed_description>
	<mesh_term>Keratitis</mesh_term>
	<mesh_term>Corneal Ulcer</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Natamycin</mesh_term>
	<criteria>Ulcer size 5 mm Ulcer depth upto 70 % stromal depth Corneal thickness 400 micron Corneal thickness 400 micron Ulcers involve limbus Pregnant woman Children age 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>fungal keratitis</keyword>
	<keyword>collagen cross link</keyword>
</DOC>